AU2003298611A1 - Mixed lineage kinase modulators - Google Patents

Mixed lineage kinase modulators

Info

Publication number: AU2003298611A1
Authority: AU; Australia
Prior art keywords: mixed lineage; kinase modulators; lineage kinase; modulators; mixed
Prior art date: 2002-11-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003298611A

Inventor

Arindam Chatterjee

Theodore Junior Goodson

Mary Margaret Mader

John Eldon Toth

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-21

Filing date

2003-11-12

Publication date

2004-06-18

2003-11-12 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

2004-06-18 Publication of AU2003298611A1 publication Critical patent/AU2003298611A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AU2003298611A 2002-11-21 2003-11-12 Mixed lineage kinase modulators Abandoned AU2003298611A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42832202P	2002-11-21	2002-11-21
US60/428,322		2002-11-21
PCT/US2003/035036 WO2004048383A1 (en)	2002-11-21	2003-11-12	Mixed lineage kinase modulators

Publications (1)

Publication Number	Publication Date
AU2003298611A1 true AU2003298611A1 (en)	2004-06-18

Family

ID=32393381

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003298611A Abandoned AU2003298611A1 (en)	2002-11-21	2003-11-12	Mixed lineage kinase modulators

Country Status (5)

Country	Link
EP (1)	EP1567528A1 (en)
JP (1)	JP2006522735A (en)
AU (1)	AU2003298611A1 (en)
CA (1)	CA2506799A1 (en)
WO (1)	WO2004048383A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA80571C2 (en)	2002-11-22	2007-10-10	Lilly Co Eli	Quinolinyl-pyrrolopyrazoles
CR9465A (en) *	2005-03-25	2008-06-19	Surface Logix Inc	PHARMACOCINETICALLY IMPROVED COMPOUNDS
SI1910370T1 (en)	2005-07-22	2015-06-30	Eli Lilly And Company	A pyridin quinolin substituted pyrrolo (1,2-b) pyrazole monohydrate as tgf-beta inhibitor
US7919519B2 (en)	2005-11-23	2011-04-05	Epix Pharmaceuticals Inc.	S1P receptor modulating compounds and use thereof
EP1965807A4 (en) *	2005-11-23	2010-10-27	Epix Delaware Inc	S1p receptor modulating compounds and use thereof
AR060050A1 (en)	2006-03-21	2008-05-21	Epix Delaware Inc	MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME
NZ623002A (en)	2006-06-26	2015-08-28	Akebia Therapeutics Inc	Prolyl hydroxylase inhibitors and methods of use
JP5191497B2 (en) *	2007-03-21	2013-05-08	エピックスファーマシューティカルズ，インコーポレイテッド	S1P receptor modulating compounds and uses thereof
JP2010540438A (en)	2007-09-20	2010-12-24	アムジエン・インコーポレーテツド	1- (4-Benzylbenzamido) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as S1P receptor modulators for treating immune disorders
DE102009001438A1 (en)	2009-03-10	2010-09-16	Bayer Schering Pharma Aktiengesellschaft	New carbonylamino-substituted anilino-pyrimidine compounds are tyrosine kinase-2 inhibitors, useful for treating diseases associated with inflammatory conditions e.g. bronchitis, rheumatoid arthritis, psoriasis and Guillain Barre syndrome
DE102009015070A1 (en)	2009-03-30	2010-10-14	Bayer Schering Pharma Aktiengesellschaft	New phenyl-pyrimidin-2-yl-amine compounds are tyrosine kinase 2 inhibitors useful for treating e.g. rheumatoid arthritis, Crohn's disease, asthma, multiple sclerosis, adult respiratory distress syndrome, allergic alveolitis and uveitis
US20120329836A1 (en)	2011-06-06	2012-12-27	The Ohio State University	Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
NO2686520T3 (en)	2011-06-06	2018-03-17
SI3007695T1 (en)	2013-06-13	2024-04-30	Akebia Therapeutics, Inc.	Compositions and methods for treating anemia
JP2018502882A (en)	2015-01-23	2018-02-01	アケビアセラピューティクスインコーポレイテッドＡｋｅｂｉａＴｈｅｒａｐｅｕｔｉｃｓＩｎｃ．	Solid form of 2- (5- (3-fluorophenyl) -3-hydroxypicolinamide) acetic acid, its composition and use
EP3277673B1 (en)	2015-04-01	2022-05-04	Rigel Pharmaceuticals, Inc.	Tgf-beta inhibitors
HRP20211862T1 (en)	2015-04-01	2022-03-04	Akebia Therapeutics, Inc.	PREPARATIONS FOR AND PROCEDURES FOR THE TREATMENT OF ANEMIA
CN107663206B (en)	2016-07-29	2021-06-18	上海璎黎药业有限公司	Nitrogen-containing aromatic heterocyclic compound, its preparation method, pharmaceutical composition and application
CN110066277B (en)	2018-01-24	2021-07-23	上海璎黎药业有限公司	Aromatic heterocyclic substituted olefin compound, preparation method, pharmaceutical composition and application thereof
CN110066276B (en)	2018-01-24	2020-09-18	上海璎黎药业有限公司	Aromatic heterocyclic compound, intermediate thereof, preparation method, pharmaceutical composition and application
TWI822776B (en)	2018-05-09	2023-11-21	美商阿克比治療有限公司	Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
CN114437082B (en) *	2020-11-06	2025-04-04	江苏先声药业有限公司	Quinoline compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5356897A (en) *	1991-09-09	1994-10-18	Fujisawa Pharmaceutical Co., Ltd.	3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
CZ303808B6 (en) *	2001-05-24	2013-05-09	Eli Lilly And Company	Novel pyrrole derivatives as pharmaceutical agents

2003
- 2003-11-12 CA CA002506799A patent/CA2506799A1/en not_active Abandoned
- 2003-11-12 JP JP2004555371A patent/JP2006522735A/en not_active Withdrawn
- 2003-11-12 EP EP03796362A patent/EP1567528A1/en not_active Withdrawn
- 2003-11-12 WO PCT/US2003/035036 patent/WO2004048383A1/en not_active Ceased
- 2003-11-12 AU AU2003298611A patent/AU2003298611A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004048383A1 (en)	2004-06-10
CA2506799A1 (en)	2004-06-10
JP2006522735A (en)	2006-10-05
EP1567528A1 (en)	2005-08-31

Publication	Publication Date	Title
AU2003298611A1 (en)	2004-06-18	Mixed lineage kinase modulators
AU2003249369A1 (en)	2004-01-06	Certain amino-substituted monocycles as kinase modulators
AU2003245773A1 (en)	2003-09-04	Vanilloid receptor modulators
AU2003253535A1 (en)	2004-03-11	N-4-piperidinyl compounds as ccr5 modulators
AU2003245669A1 (en)	2004-01-06	Certain aromatic monocycles as kinase modulators
AU2003233704A1 (en)	2003-12-19	Electro-optic modulators
AU2002345661A1 (en)	2003-10-27	Display devices with organic-metal mixed layer
AU2003225031A1 (en)	2003-11-11	Eptfe-reinforced perfluoroelastomers
AU2002951247A0 (en)	2002-09-19	Compounds that interact with kinases
AU2003253880A1 (en)	2004-02-02	Novel kinases
AU2003223405A1 (en)	2003-11-17	Technique for distributing sotware background
AU2003301654A1 (en)	2004-05-13	Stabilized composition
AU2003241601A1 (en)	2003-12-12	Anilino liver x-receptor modulators
AU2003272552A1 (en)	2004-04-08	Aromatic liver x-receptor modulators
AU2002324354A1 (en)	2004-01-19	Mixing apparatus
AU2003221577A1 (en)	2003-11-17	Entitlements administration
AU2003226487A1 (en)	2003-09-22	Formulation
AU2003218991A1 (en)	2003-09-16	Colouring agents
AU2003206210A1 (en)	2004-05-13	Educational block set
AU2003205970A1 (en)	2004-08-30	Software distribution
AU2003217110A1 (en)	2003-09-16	Novel formulation
EP1581309A4 (en)	2009-07-29	Kinase modulators
AU2002367757A1 (en)	2003-09-22	Mixer
AU2003303520A1 (en)	2004-07-29	Irs modulators
AU2003260697A1 (en)	2004-02-09	Image colouring

Legal Events

Date	Code	Title	Description
2005-09-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase